There were 1,546 press releases posted in the last 24 hours and 358,748 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image